Nordisk

The U.S. Senate health panel announced on Tuesday that it would vote this month on whether to subpoena Novo Nordisk to address questions about the high U.S. prices for its weight loss drugs Ozempic and Wegovy, which are significantly higher than those in other countries. The Senate Committee on Health, Education, Labor, and Pensions (HELP)…